Nootropic Supplement Smart Drug Idra 21 for Memory Improvement Idra-21

• Post Date:

  Sep 30,2017

• Expiry Date:

  Sep 30,2018

• Detailed Description:

  details.:ulalee@yuanchengtech.com
  ,whatsapp: +8618872220744
  Nootropic Supplement Smart Drug Idra 21 for Memory Improvement Idra-21
  Nootropic Chemical Powder Supplement Noopept Idra-21 for Brain Idra 21
  Identification
  Name
  7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
  Synonyms IDRA 21
  Solubility: Sparingly Soluble (0.93 g/L) (25 ºC), Calc.*
  Molecular Formula C8H9ClN2O2S
  Molecular Weight 232.69
  CAS Registry Number 22503-72-6
  Storage Store at room temperature
  Properties
  Melting point 209 ºC (acetic acid )**
  
  Introduction
  IDRA-21 is an ampakine drug and a benzothiadiazine derivative. IDRA-21 is a chiral molecule, with (+)-IDRA-21 being the active form.
  IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits, and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
  IDRA-21 does not produce neurotoxicity under normal conditions, although it may worsen neuronal damage following global ischemia after stroke or seizures.
  In comparison to the benzoylpiperidine derived ampakine drugs, IDRA-21 was more potent than CX-516, but less potent than CX-546.[8] Newer benzothiadiazide derivatives with greatly increased potency compared to IDRA-21 have been developed,but these have not been researched to the same extent, with the benzoylpiperidine and benzoylpyrrolidine CX-series of drugs being favoured for clinical development, most likely due to more favourable toxicity profiles at high doses.
  
  In comparison to the benzoylpiperidine derived ampakine drugs, IDRA-21 was more potent than CX-516, but less potent than CX-546. Newer benzothiadiazide derivatives with greatly increased potency compared to IDRA-21 have been developed, but these have not been researched to the same extent, with the benzoylpiperidine and benzoylpyrrolidine CX-series of drugs being favoured for clinical development, most likely due to more favourable toxicity profiles at high doses.
  
  IDRA-21 Benefits
  
  1. Increase in cognition.
  2. Increase Task Accuracy
  3. Increases in Short Term Memory
  4. Potential Therapeutic Effects On Schizophrenia
  5. Potental Therapeutic Effects On Depression
  6. Neuroprotection
  
  IDRA-21 Mechanism Of Action

• Company:

  hubei gongchuang ltd.c     [ China ]        

• Contact:

  ulalee

• Tel:

  +86-571-15784251

• Fax:

• Email:

  gcgj11@ycphar.com